Sign in Subscribe

IFF Sells Food Ingredients Unit for $4.3 Billion: A Strategic Shift Toward High-Growth Segments

Editor

• 3 min read
Share
IFF Sells Food Ingredients Unit for $4.3 Billion: A Strategic Shift Toward High-Growth Segments

May 29, 2026

In a landmark move reshaping the specialty ingredients landscape, International Flavors & Fragrances (IFF) has agreed to sell its core Food Ingredients business to private equity firm CVC Capital Partners for $4.3 billion. This divestiture marks a pivotal step in IFF’s multi-year strategy to streamline operations, reduce debt, and pivot toward higher-margin, faster-growing sectors like health, biosciences, and advanced scent technologies.

The transaction, expected to close by the end of the second quarter of 2027, will see IFF retain a 10% stake in the divested unit. This allows the parent company to maintain collaborative ties and benefit from future growth, while significantly sharpening its own portfolio focus.

Background: A Legacy of Mega-Mergers and Strategic Reversal

To understand the scale of this sale, one must look back at IFF’s recent history. In 2021, IFF completed a massive $26.2 billion acquisition of DuPont’s Nutrition & Biosciences business. While the deal aimed to create a global leader in high-value ingredients, it also left IFF with a sprawling, complex portfolio and elevated debt levels. The newly acquired food texturants, emulsifiers, and plant-based solutions—while generating substantial revenue—often operated in lower-growth, commodity-adjacent markets.

Since then, IFF has been on a deliberate divestiture path. CEO Erik Fyrwald, who took the helm in 2023, has prioritized selling non-core assets. Prior to this $4.3 billion deal, IFF had already sold 13 non-core businesses, generating nearly $10 billion in gross proceeds. The sale of the Food Ingredients division represents the largest and most significant of these portfolio simplifications.

Details of the Transaction: What Is Being Sold?

The Food Ingredients business being sold is IFF’s largest division by revenue, generating approximately $3.3 billion in sales in 2025. However, it also showed signs of stagnation, declining 3% compared to the prior year.

Specifically, the divested unit includes:

  • Texturants: Systems that modify the mouthfeel, stability, and structure of processed foods (e.g., dairy, baked goods, confectionery).
  • Emulsifiers: Ingredients critical for blending oil and water in products like margarine, dressings, and ice cream.
  • Plant-based solutions: Stabilizers and binders used in meat alternatives and dairy-free products.

Notably, the sale does not include IFF’s higher-growth Nourish division (taste solutions) or its Health & Biosciences segments. Those remain core to IFF’s future.

Strategic Rationale: Why IFF Is Selling

For IFF, this divestiture is about focus and financial discipline. In a statement, CEO Erik Fyrwald explained: “This transaction represents an important strategic milestone in our ongoing portfolio optimization initiative, allowing us to further concentrate resources on our higher-growth, higher-margin segments.”

Following the sale, IFF will center its operations on three core businesses:

  1. Scent (fine fragrances and consumer perfumes)
  2. Taste (flavor solutions for beverages and savory foods – this segment generated $2.5 billion in 2025)
  3. Health & Biosciences (enzymes, probiotics, and food protection)

These remaining divisions typically command higher margins and benefit from long-term trends in wellness, clean labels, and natural ingredients. The $4.3 billion in cash proceeds (plus the retained equity stake) will likely be used to accelerate debt reduction and fund targeted R&D in biotech-based solutions.

A Broader Wave of M&A in the Ingredients Industry

The IFF-CVC deal is not happening in a vacuum. The transaction is a headline event in what is shaping up to be a very active period of M&A activity in the food ingredients space:

  • Tate & Lyle recently confirmed it is considering a £2.7 billion ($3.7 billion) takeover bid from larger rival Ingredion, a move that would consolidate the sweeteners and texturants market.
  • Splenda owner Heartland Food Products agreed to acquire the Americas business of Whole Earth Brands, which owns the competing sugar substitute brand Equal.

These deals reflect a broader industry trend: large ingredient suppliers are rebalancing their portfolios, while private equity firms like CVC see stable, cash-generating B2B ingredient businesses as attractive long-term investments.

What This Means for Food Manufacturers

For food and beverage companies that purchase ingredients from IFF, the immediate impact should be minimal. The Food Ingredients unit will continue operations under CVC ownership, likely with a renewed focus on cost efficiency and customer service. However, long-term, manufacturers should watch for potential changes in pricing, product innovation pipelines, and supply chain agreements as the new ownership takes over.

IFF’s retained 10% stake suggests a continued technical or commercial alliance, ensuring some level of continuity for shared customers.

Conclusion and Outlook

The $4.3 billion sale of IFF’s Food Ingredients business to CVC Capital Partners is a definitive move to undo the complexity of the 2021 DuPont merger. By shedding its largest but slowest-growth unit, IFF is doubling down on premium taste, scent, and bioscience solutions—areas aligned with future consumer demand for health, wellness, and sensory experience.

For CVC, the acquisition provides a market-leading platform with $3.3 billion in annual sales, deep customer relationships, and potential for operational improvements. As the ingredients sector continues to consolidate and streamline, this deal will be studied as a blueprint for portfolio transformation.

###